Physician
Thedacare, Incorporated
Thedacare, Incorporated was paid $14.90M by Medicaid between Jan 2018 and Dec 2024, across 144 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoTHEDACARE, INCORPORATED
NEW LONDON, WI 54961
NEW LONDON, WI 54961
33aNPI1376656959assigned 08/16/2006
33bProvider typeFamily Medicine Physician
28Total paid$14.90M
24GClaims480,918
24DCodes billed144
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Wisconsin
Rank by total paid#3 of 359
Median peer was paid$4K
This provider vs. median3,831×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FLETT, WILLIAM controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 66,946 | $1.80M | |
| 2019 | 68,186 | $1.85M | |
| 2020 | 48,519 | $1.38M | |
| 2021 | 70,215 | $2.07M | |
| 2022 | 78,296 | $2.37M | |
| 2023 | 84,656 | $2.46M | |
| 2024incomplete | 64,100 | $2.98M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 157,794 | 142,991 | $6.32M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 186,510 | 169,956 | $5.50M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 8,162 | 7,422 | $369K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 1.8% | 13,034 | 12,225 | $268K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.6% | 4,099 | 3,845 | $236K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 3,737 | 3,623 | $217K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.2% | 7,934 | 4,706 | $175K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.1% | 2,585 | 2,385 | $160K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.0% | 5,255 | 4,804 | $154K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 4,368 | 4,108 | $134K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,061 | 1,995 | $118K |
| 90686 | <1% | 15,484 | 14,938 | $118K |
132 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,915 | $86K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 14,653 | $83K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 105 | $78K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,392 | $68K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,990 | $58K |
| 3008F | <1% | 5,854 | $53K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,144 | $46K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 2,880 | $41K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 98 | $35K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 427 | $34K |
| J2315 | Injection, naltrexone, depot form, 1 mg | <1% | 29 | $29K |
| 20611 | <1% | 764 | $29K | |
| 93227 | <1% | 1,645 | $25K | |
| 87631 | <1% | 240 | $24K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 60 | $23K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,003 | $22K |
| 0002A | <1% | 552 | $20K | |
| 93000 | <1% | 1,776 | $18K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 304 | $17K |
| 0001A | <1% | 529 | $17K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 894 | $13K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 251 | $13K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 19 | $13K |
| 0072A | <1% | 385 | $12K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 183 | $12K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 753 | $12K |
| 93296 | <1% | 1,107 | $12K | |
| 0071A | <1% | 383 | $11K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 261 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,518 | $11K |
| 99223 | Prolong inpt eval add15 m | <1% | 228 | $11K |
| 90677 | <1% | 188 | $10K | |
| 0012A | <1% | 266 | $10K | |
| 0011A | <1% | 292 | $10K | |
| 93018 | <1% | 960 | $9K | |
| 0004A | <1% | 225 | $7K | |
| 95886 | <1% | 124 | $7K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 332 | $7K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,119 | $7K |
| 90670 | <1% | 1,706 | $7K | |
| 92551 | <1% | 474 | $6K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 136 | $6K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 182 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 511 | $5K |
| 99349 | <1% | 161 | $5K | |
| 93294 | <1% | 425 | $5K | |
| 0064A | <1% | 156 | $5K | |
| 80061 | Lipid panel | <1% | 429 | $5K |
| 93016 | <1% | 300 | $4K | |
| 99205 | Prolong outpt/office vis | <1% | 60 | $4K |
| 90723 | <1% | 724 | $4K | |
| 80306 | <1% | 189 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 15 | $3K |
| 20610 | <1% | 87 | $3K | |
| 80076 | <1% | 367 | $3K | |
| 90647 | <1% | 450 | $3K | |
| 99421 | <1% | 326 | $3K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 20 | $2K |
| 0124A | <1% | 73 | $2K | |
| 95251 | <1% | 153 | $2K | |
| 93295 | <1% | 67 | $2K | |
| 90680 | <1% | 384 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 576 | $2K |
| 64644 | <1% | 56 | $2K | |
| 0031A | <1% | 47 | $2K | |
| 93272 | <1% | 81 | $2K | |
| 99336 | <1% | 58 | $2K | |
| 62323 | <1% | 14 | $1K | |
| 90685 | <1% | 425 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 218 | $1K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 63 | $1K |
| 72170 | <1% | 110 | $1K | |
| 0052A | <1% | 46 | $1K | |
| 73610 | <1% | 92 | $1K | |
| 99220 | <1% | 28 | $1K | |
| 90688 | <1% | 83 | $1K | |
| 90656 | <1% | 73 | $1K | |
| 99152 | <1% | 67 | $977.01 | |
| 73564 | <1% | 56 | $976.86 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 27 | $883.33 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 154 | $869.41 |
| 0054A | <1% | 29 | $847.52 | |
| 73630 | <1% | 57 | $830.72 | |
| 0134A | <1% | 27 | $804.78 | |
| 95874 | <1% | 99 | $735.53 | |
| 11045 | <1% | 74 | $693.28 | |
| 99219 | <1% | 12 | $670.62 | |
| 73030 | <1% | 41 | $656.33 | |
| 81001 | <1% | 193 | $587.24 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $548.80 |
| 0154A | <1% | 16 | $534.24 | |
| 99174 | <1% | 2,267 | $526.67 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 64 | $502.20 |
| 73110 | <1% | 16 | $420.91 | |
| 99335 | <1% | 37 | $376.95 | |
| 20552 | <1% | 17 | $316.90 | |
| 90633 | <1% | 90 | $316.48 | |
| 93308 | <1% | 14 | $301.50 | |
| 97597 | <1% | 22 | $252.59 | |
| 73552 | <1% | 19 | $232.68 | |
| 99305 | <1% | 13 | $221.34 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 527 | $214.18 |
| 72100 | <1% | 16 | $210.02 | |
| 99497 | <1% | 13 | $197.56 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 13 | $193.73 |
| 73562 | <1% | 14 | $183.19 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12 | $172.09 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 14 | $147.50 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15 | $137.96 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 52 | $137.51 |
| 99173 | <1% | 12 | $130.80 | |
| 93321 | <1% | 14 | $86.36 | |
| 90734 | <1% | 26 | $79.74 | |
| 90651 | <1% | 26 | $79.54 | |
| 90715 | <1% | 13 | $67.99 | |
| 93325 | <1% | 29 | $59.14 | |
| 99406 | <1% | 12 | $33.37 | |
| 81003 | <1% | 13 | $22.50 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 26 | $9.45 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $4.35 |
| 91313 | 0% | 24 | $0.00 | |
| 91300 | 0% | 1,424 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 14 | $0.00 |
| 97803 | 0% | 27 | $0.00 | |
| 91311 | 0% | 15 | $0.00 | |
| 91312 | 0% | 71 | $0.00 | |
| 91307 | 0% | 819 | $0.00 | |
| 91301 | 0% | 613 | $0.00 | |
| 91306 | 0% | 151 | $0.00 | |
| 91305 | 0% | 116 | $0.00 | |
| 91315 | 0% | 16 | $0.00 | |
| 91303 | 0% | 108 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFLETT, WILLIAM (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.